You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Antengene to collaborate with LegoChem Biosciences for antibody-drug conjugates

Antengene, a clinical stage biopharmaceutical company, is to enter into a Research Collaboration and License Option Agreement with LegoChem Biosciences (LCB), for new antibody-drug conjugates (ADCs).